antalarmin has been researched along with Anxiety Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bashiri, H; Kosari-Nasab, M; Sadeghi, T; Salari, AA; Shokouhi, G | 1 |
Jia, J; Li, JT; Liao, XM; Liu, R; Schmidt, MV; Si, TM; Su, YA; Uribe-MariƱo, A; Wang, XD; Xie, XM; Yang, XD | 1 |
2 other study(ies) available for antalarmin and Anxiety Disorders
Article | Year |
---|---|
The blockade of corticotropin-releasing factor 1 receptor attenuates anxiety-related symptoms and hypothalamus-pituitary-adrenal axis reactivity in mice with mild traumatic brain injury.
Topics: Adrenocorticotropic Hormone; Animals; Anxiety; Anxiety Disorders; Brain Concussion; Corticosterone; Corticotropin-Releasing Hormone; Disease Models, Animal; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred Strains; Pituitary-Adrenal System; Pyrimidines; Pyrroles; Receptors, Corticotropin-Releasing Hormone; Stress, Physiological | 2019 |
Stress during a critical postnatal period induces region-specific structural abnormalities and dysfunction of the prefrontal cortex via CRF1.
Topics: Animals; Animals, Newborn; Anxiety Disorders; Cognition Disorders; Dendritic Spines; Disease Models, Animal; Female; Hormone Antagonists; Male; Mice, Inbred C57BL; Prefrontal Cortex; Pyramidal Cells; Pyrimidines; Pyrroles; Random Allocation; Receptors, Corticotropin-Releasing Hormone; Stress, Psychological | 2015 |